Acute respiratory distress syndrome: focusing on secondary injury

来源 :中华医学杂志英文版 | 被引量 : 0次 | 上传用户:shenkan8009
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Acute respiratory distress syndrome (ARDS) is one of the most common severe diseases seen in the clinical setting. With the continuous exploration of ARDS in recent decades, the understanding of ARDS has improved. ARDS is not a simple lung disease but a clinical syndrome with various etiologies and pathophysiological changes. However, in the intensive care unit, ARDS often occurs a few days after primary lung injury or after a few days of treatment for other severe extrapulmonary diseases. Under such conditions, ARDS often progresses rapidly to severe ARDS and is difficult to treat. The occurrence and development of ARDS in these circumstances are thus not related to primary lung injury; the real cause of ARDS may be the “second hit” caused by inappropriate treatment. In view of the limited effective treatments for ARDS, the strategic focus has shifted to identifying potential or high-risk ARDS patients during the early stages of the disease and implementing treatment strategies aimed at reducing ARDS and related organ failure. Future research should focus on the prevention of ARDS.“,”Acute respiratory distress syndrome (ARDS) is one of the most common severe diseases seen in the clinical setting. With the continuous exploration of ARDS in recent decades, the understanding of ARDS has improved. ARDS is not a simple lung disease but a clinical syndrome with various etiologies and pathophysiological changes. However, in the intensive care unit, ARDS often occurs a few days after primary lung injury or after a few days of treatment for other severe extrapulmonary diseases. Under such conditions, ARDS often progresses rapidly to severe ARDS and is difficult to treat. The occurrence and development of ARDS in these circumstances are thus not related to primary lung injury; the real cause of ARDS may be the “second hit” caused by inappropriate treatment. In view of the limited effective treatments for ARDS, the strategic focus has shifted to identifying potential or high-risk ARDS patients during the early stages of the disease and implementing treatment strategies aimed at reducing ARDS and related organ failure. Future research should focus on the prevention of ARDS.
其他文献
目的通过比较MRI去金属伪影WARP序列与常规序列图像,探讨WARP序列能否为关节假体周围感染(PJI)患者提供更清晰、准确的肌肉骨骼图像及手术指导作用。方法回顾性分析2020年1月至2021年2月于福建医科大学附属第一医院诊断为PJI并接受治疗的23例患者资料。男10例,女13例;年龄为32~88岁(平均62.8岁)。根据扫描方式不同分为2组:WARP组14例(接受WARP序列扫描),常规组9例
由中国医师协会风湿免疫科医师分会影像学组和国内同领域专家在参考国外同类指南、共识和相关领域发表研究结果的基础上,结合国内临床诊治经验和证据制定的影像学技术在SpA中应用的首个中国专家共识,旨在提高国内风湿科医生对影像学技术的原理、在SpA中的生理、病理表现的认识水平,并规范其在该领域的合理使用。
目的探讨OA发病机制中潜在的Hub基因、关键miRNAs、生物过程及相关信号通路,为OA的发病机制及治疗提供生物信息学依据。方法从基因表达综合数据库(GEO)下载OA滑膜组织样本的表达谱芯片,鉴定差异表达基因DEGs,并进行功能富集分析。构建蛋白-蛋白相互作用网络(PPI),STRING和Cytoscape进行模块分析,进一步鉴定Hub基因,并对Hub基因进行更深一步的miRNAs挖掘。结果最终鉴
SSc是一种以皮肤和器官纤维化、血管病变为特征的结缔组织疾病。IL-35是IL-12家族的新成员,促进调节性T细胞(Treg)的增殖并增强Treg细胞的抑制功能,抑制辅助性T细胞(Th)17的分化及IL-17的分泌,还诱导产生调节性B细胞(Breg),促进其向分泌IL-35、IL-10的Breg细胞转化,发挥免疫抑制作用。目前SSc的发病机制尚未完全明确,IL-35在SSc发病中的作用仍存有争议。
乳腺癌新辅助治疗是局部晚期乳腺癌综合治疗的重要手段之一,包括化疗和内分泌治疗。PET能够通过早期观察肿瘤代谢变化预测新辅助治疗疗效,有望指导个体化治疗决策的制定。本文将综述PET多参数在乳腺癌新辅助治疗疗效预测中的应用现状,并结合影像组学和PET特异性分子影像探针等介绍其研究进展。
腹腔干因正中弓状韧带压迫而狭窄的患者中多可见以胰十二指肠动脉弓为主的侧支循环形成,胰十二指肠切除术中切除胰头侧支后可并发急性正中弓状韧带压迫综合征。本文介绍1例经支架植入手术治疗而获得康复的病例,提示介入手术可作为此病症的有效治疗手段,且特别适用于难以耐受外科手术的患者。
目的探讨脓毒症小鼠中性粒细胞对T淋巴细胞(T细胞)功能的影响以及CD80/细胞毒性T淋巴细胞抗原-4(CTLA-4)途径在其中发挥的作用。方法①体内实验:将6~8周龄雄性C57BL/6小鼠按照随机数字表法分为假手术组(Sham组,n=20)、Sham+CTLA-4抗体处理组(Sham+aCTLA-4组,n=20)、盲肠结扎穿孔术(CLP)致脓毒症模型组(CLP组,n=30)和CLP+CTLA-4抗
目的比较锁定加压接骨板(LCP)动力化联合自体骨移植与单纯植骨手术治疗股骨无菌性骨不连的疗效。方法回顾性分析2010年1月至2020年1月解放军中部战区总医院骨科收治的30例股骨骨折无菌性骨不连的患者资料。男19例,女11例;年龄25~55岁。根据手术方式不同分为:A组12例(采用LCP动力化联合自体骨移植术治疗)和B组18例(采用单纯植骨术治疗)。比较两组患者的各项手术指标、骨折愈合时间、术前及
SSc是一种免疫介导的CTD,其特征是皮肤和内脏纤维化以及微血管病变,常见的受累脏器包括皮肤、胃肠道、肺、心、肾。本研究报道1例SSc所致心肌纤维化,继发扩张型心肌病、心功能不全[纽约心脏病协会(NYHA) Ⅳ级],表现为胸闷气促、皮肤硬化、雷诺现象和肺间质病变,抗Scl-70抗体阳性,并携带肌球蛋白重链7(MYH7)基因和JUP基因变异。SSc累及心脏病临床表现隐匿,有明显心脏受累表现时往往预后